Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for Gastroprotection in IHD Patients on Aspirin
NCT05553717Unknown
- Sponsor
- Tanta University
- Start
- Oct 2022
- Primary completion
- Oct 2023
01
Overview
Randomised trial of carvedilol in gastric ulcer and Esophageal ulcer (2 arms), sponsored by Tanta University. Primary endpoints: Change in gastrointestinal symptoms at 3 months and Quality of life at 3 months. Status: unknown.
02
Drugs
carvedilol
03
Conditions
gastric ulcerEsophageal ulcer
Beyond the preview
Go deeper on NCT05553717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05553717.